Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Devane

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Journal of Toxicology. Clinical Toxicology|May 1, 1982
Hemoperfusion for imipramine overdose: elimination of active metabolitesP R Pentel, M L Bullock, C L DeVane
Psychopharmacology Bulletin|January 1, 1991
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methodsC L DeVane, M V Rudorfer, W Z Potter
Clinical Neuropharmacology|January 1, 1992
Steady-state predictions based on first dose dataW Z Potter, C L DeVane, M V Rudorfer
The Journal of Clinical Psychiatry|April 1, 1982
Toxic hepatitis and single daily dosage imipramine therapyR Moskovitz, C L DeVane, R Harris, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
Influence of menstrual cycle and gender on alprazolam pharmacokineticsC Kirkwood, A Moore, P Hayes, et al.
Developmental Pharmacology and Therapeutics|January 1, 1991
Disposition of cocaine in pregnant sheep. II. Physiological responsesD J Burchfield, R M Abrams, R Miller, et al.
The Journal of Clinical Psychiatry|August 24, 1999
Mirtazapine in major depression with comorbid generalized anxiety disorderP J Goodnick, A Puig, C L DeVane, et al.
Die Pharmazie|March 28, 2009
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptorJ S Markowitz, C L DeVane, S Ramamoorthy, et al.
Psychosomatic Medicine|June 14, 2000
Sertraline in diabetic neuropathy: response and biologyP J Goodnick, L Mendosa, A Kumar, et al.
Biological Psychiatry|October 27, 1998
Bupropion slow-release response in depression: diagnosis and biochemistryP J Goodnick, R A Dominguez, C L DeVane, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Journal of Toxicology. Clinical Toxicology|May 1, 1982
Hemoperfusion for imipramine overdose: elimination of active metabolitesP R Pentel, M L Bullock, C L DeVane
Psychopharmacology Bulletin|January 1, 1991
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methodsC L DeVane, M V Rudorfer, W Z Potter
Clinical Neuropharmacology|January 1, 1992
Steady-state predictions based on first dose dataW Z Potter, C L DeVane, M V Rudorfer
The Journal of Clinical Psychiatry|April 1, 1982
Toxic hepatitis and single daily dosage imipramine therapyR Moskovitz, C L DeVane, R Harris, et al.
Clinical Pharmacology and Therapeutics|October 1, 1991
Influence of menstrual cycle and gender on alprazolam pharmacokineticsC Kirkwood, A Moore, P Hayes, et al.
Developmental Pharmacology and Therapeutics|January 1, 1991
Disposition of cocaine in pregnant sheep. II. Physiological responsesD J Burchfield, R M Abrams, R Miller, et al.
The Journal of Clinical Psychiatry|August 24, 1999
Mirtazapine in major depression with comorbid generalized anxiety disorderP J Goodnick, A Puig, C L DeVane, et al.
Die Pharmazie|March 28, 2009
The psychostimulant d-threo-(R,R)-methylphenidate binds as an agonist to the 5HT(1A) receptorJ S Markowitz, C L DeVane, S Ramamoorthy, et al.
Psychosomatic Medicine|June 14, 2000
Sertraline in diabetic neuropathy: response and biologyP J Goodnick, L Mendosa, A Kumar, et al.
Biological Psychiatry|October 27, 1998
Bupropion slow-release response in depression: diagnosis and biochemistryP J Goodnick, R A Dominguez, C L DeVane, et al.
Pageof 13